Sebia in the news
global in vitro diagnostics
Tamtam found 20 recent articles about Sebia.
- Sebia India collaborates with CAHO to launch autoimmunity masterclass series
Sebia India and CAHO have launched a six-part webinar series to train healthcare professionals on diagnosing and managing rising autoimmune disease cases.
- Nitin Wadhwa joins Sebia as General Manager to lead India growth
Sebia has appointed industry veteran Nitin Wadhwa as General Manager to lead its business growth and diagnostic market expansion in India.
- Sebia India collaborates with CAHO to launch autoimmunity masterclass series
Sebia India partnered with CAHO to launch a masterclass series aimed at improving the diagnosis and clinical management of autoimmune diseases.
- Sebia names Nitin Wadhwa as GM
Sebia appointed Nitin Wadhwa as General Manager for its Indian operations to expand its presence in the diagnostics market.
- Sebia announces appointment of Nitin Wadhwa as General Manager, India
Nitin Wadhwa has been appointed as General Manager for India to lead commercial strategy and market expansion.
- EU Commission clears acquisition of Sebia by Warburg Pincus
Warburg Pincus has received European Commission approval to acquire Sebia, a specialist in in-vitro diagnostic technologies.
- Abionyx Pharma et SEBIA annoncent un partenariat stratégique exclusif mondial pour transformer le diagnostic du sepsis
Abionyx Pharma and Sebia partner globally to develop innovative diagnostic tests for early and accurate sepsis detection and management.
- Abionyx Pharma signe un partenariat stratégique exclusif avec SEBIA dans le sepsis
Abionyx Pharma and SEBIA partner to develop advanced diagnostic tests for earlier and more precise sepsis detection and treatment monitoring.
- Abionyx Pharma et SEBIA annoncent un partenariat stratégique exclusif mondial pour transformer le di...
Abionyx Pharma and SEBIA have partnered globally to develop advanced diagnostic tests for early sepsis detection and treatment monitoring.
- Abionyx Pharma conclut avec le francilien Sebia un partenariat stratégique pour transformer le diagnostic du sepsis
Abionyx Pharma and Sebia partner to develop advanced diagnostic tests for earlier and more precise sepsis detection and treatment monitoring.
- ABIONYX Pharma et SEBIA annoncent un partenariat stratégique mondial exclusif pour transformer le diagnostic de la sepsie
ABIONYX Pharma and SEBIA partnered to develop advanced diagnostic tests for earlier and more accurate sepsis detection and management.
- ABIONYX Pharma and SEBIA Announce an Exclusive Global Strategic Partnership to Transform Sepsis Diagnosis
ABIONYX Pharma and SEBIA partnered to develop advanced diagnostic tests for earlier, more accurate sepsis detection and treatment monitoring.
- ABIONYX Pharma and SEBIA Announce an Exclusive Global Strategic Partnership to Transform Sepsis Diagnosis
ABIONYX Pharma and SEBIA have partnered to develop advanced diagnostic tests for early sepsis detection and treatment monitoring, combining biotherapy and specialized diagnostics expertise.
- Abionyx Pharma signe un partenariat stratégique exclusif avec SEBIA dans le sepsis
Abionyx Pharma and SEBIA partner to develop advanced diagnostic tests for earlier and more precise sepsis detection and treatment monitoring.
- ABIONYX Pharma and SEBIA form partnership for sepsis diagnostics By Investing.com
ABIONYX Pharma and SEBIA partnered to develop advanced sepsis diagnostic tests aiming for earlier detection and better treatment monitoring.
- Healthcare & Life Sciences Private Equity Deal Tracker: Warburg Pincus to Acquire Stake in Sebia
Warburg Pincus plans to acquire a significant minority stake in specialty diagnostics company Sebia, with closing expected by Q1 2026.
- Willkie conseille les fonds CVC dans le cadre de leur entrée en négociations exclusives en vue de la cession d’une participation minoritaire significative et de leur réinvestissement dans Sebia
CVC funds negotiate with Warburg Pincus to sell and reinvest in Sebia, a global in vitro diagnostics company, with deal closure expected by early 2026.
- Warburg Pincus Nears Deal for Stake in France’s Sebia
Warburg Pincus is close to acquiring a 30% stake in Sebia, valuing the company at about €5.5 billion.
- Santé : un fonds américain investit au capital de la pépite française Sebia
Warburg Pincus invested €1.3 billion for a 35% stake in French diagnostic company Sebia, which focuses on niche medical tests and aims to expand in the US market.
- Warburg Pincus in talks to buy minority stake in Sebia
Warburg Pincus is negotiating to buy a minority stake in Sebia, a specialty diagnostics company, with the deal expected to close by Q1 2026.
Articles collected by Tamtam and kept when they are about the company, newest first. Each links to its source.
Selling to companies like Sebia?
Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.
Find similar companies